Business Description
Gongwin Biopharm Holdings Co Ltd
ISIN : KYG409471060
Description
Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.8 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -1.38 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 32.35 | |||||
| Beneish M-Score | -0.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 175.3 | |||||
| 3-Year EBITDA Growth Rate | 4.4 | |||||
| 3-Year EPS without NRI Growth Rate | 2.7 | |||||
| 3-Year FCF Growth Rate | 4.1 | |||||
| 3-Year Book Growth Rate | 5.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.95 | |||||
| 9-Day RSI | 52.75 | |||||
| 14-Day RSI | 51.98 | |||||
| 6-1 Month Momentum % | -19.39 | |||||
| 12-1 Month Momentum % | -34.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.28 | |||||
| Quick Ratio | 15.23 | |||||
| Cash Ratio | 14.9 | |||||
| Days Inventory | 301.54 | |||||
| Days Sales Outstanding | 117.69 | |||||
| Days Payable | 46.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | -14.07 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.58 | |||||
| Operating Margin % | -467.91 | |||||
| Net Margin % | -294.65 | |||||
| FCF Margin % | -882.66 | |||||
| ROE % | -4.44 | |||||
| ROA % | -3.96 | |||||
| ROIC % | -22.23 | |||||
| ROC (Joel Greenblatt) % | -42.36 | |||||
| ROCE % | -4.4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 409.93 | |||||
| PB Ratio | 4.44 | |||||
| Price-to-Tangible-Book | 4.4 | |||||
| EV-to-EBIT | -120.66 | |||||
| EV-to-EBITDA | -137.46 | |||||
| EV-to-Revenue | 366.22 | |||||
| EV-to-FCF | -42.39 | |||||
| Price-to-Projected-FCF | 6.82 | |||||
| Price-to-Net-Current-Asset-Value | 6.29 | |||||
| Price-to-Net-Cash | 6.47 | |||||
| Earnings Yield (Greenblatt) % | -0.83 | |||||
| FCF Yield % | -2.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gongwin Biopharm Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 31.764 | ||
| EPS (TTM) (NT$) | -0.81 | ||
| Beta | 0.02 | ||
| Volatility % | 27.32 | ||
| 14-Day RSI | 51.98 | ||
| 14-Day ATR (NT$) | 4.024417 | ||
| 20-Day SMA (NT$) | 108.725 | ||
| 12-1 Month Momentum % | -34.35 | ||
| 52-Week Range (NT$) | 96 - 217 | ||
| Shares Outstanding (Mil) | 126.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gongwin Biopharm Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gongwin Biopharm Holdings Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gongwin Biopharm Holdings Co Ltd Frequently Asked Questions
What is Gongwin Biopharm Holdings Co Ltd(ROCO:6617)'s stock price today?
The current price of ROCO:6617 is NT$110.50. The 52 week high of ROCO:6617 is NT$217.00 and 52 week low is NT$96.00.
When is next earnings date of Gongwin Biopharm Holdings Co Ltd(ROCO:6617)?
The next earnings date of Gongwin Biopharm Holdings Co Ltd(ROCO:6617) is .
Does Gongwin Biopharm Holdings Co Ltd(ROCO:6617) pay dividends? If so, how much?
Gongwin Biopharm Holdings Co Ltd(ROCO:6617) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers